Psychotic Marketing for an Antipsychotic Drug
Submitted by Diane Farsetta on
Public relations and planning documents from AstraZeneca discuss promoting "off-label" or unapproved uses for the company's drug Seroquel. The U.S. Food and Drug Administration has approved Seroquel for schizophrenia, psychotic and bipolar disorders among adults.